Figure 1.
Representative chemical structures of known Autotaxin (ATX) inhibitors reported in the literature, and GLPG1690—the first-in-class ATX inhibitor—entered in advanced clinical trials in patients suffering from idiopathic pulmonary fibrosis.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.